Clinical Trial Update: Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating iloprost for prevention of lung cancer in high-risk individuals with precancerous lung conditions; study completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Precancerous Condition

Drugs mentioned

• Iloprost (iloprost)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Lung Cancer, Precancerous Condition | Phase 2 | Status: COMPLETED | Results posted: 2013-02-13